Company description
Many cellular activities are controlled by post-translational modifications, the study of which is hampered by the lack of specific reagents due in large part to their ubiquitous and non-immunogenic nature. Creative Biolabs has developed High-Affi™ technology, which offers antibody discovery services that specific for post-translational modifications on proteins.
